Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic Review-Reference-Cited by-同舟云学术

Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic Review

Published:2018-05 Issue:5 Volume:73 Page:738-748
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Kamat Ashish M.,Li Roger,O’Donnell Michael A.,Black Peter C.,Roupret Morgan,Catto James W.,Comperat Eva,Ingersoll Molly A.,Witjes Wim P.,McConkey David J.,Witjes J. Alfred

Publisher

Elsevier BV

Subject

Urology

Reference93 articles.

1. Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors;Morales;J Urol,1976

2. EORTC Nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1-3 years of maintenance Bacillus Calmette-Guerin;Cambier;Eur Urol,2016

3. Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guerin: multivariate analysis of data from four randomized CUETO trials;Fernandez-Gomez;Eur Urol,2008

4. Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review;van den Bosch;Eur Urol,2011

5. Markers predicting response to bacillus Calmette-Guerin immunotherapy in high-risk bladder cancer patients: a systematic review;Zuiverloon;Eur Urol,2012

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HLA-E and NKG2A Mediate Resistance toM. bovisBCG Immunotherapy in Non-Muscle-Invasive Bladder Cancer;2024-09-03

2. Chest wall tumor following intravesical BCG instillation for non-muscle invasive bladder cancer;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2024-05

3. Spatial Distribution of Macrophage and Lymphocyte Subtypes within Tumor Microenvironment to Predict Recurrence of Non-Muscle-Invasive Papillary Urothelial Carcinoma after BCG Immunotherapy;International Journal of Molecular Sciences;2024-04-27

4. Low Cubilin/Myeloperoxidase ratio as a promising biomarker for prognosis of high-grade T1 bladder cancer;International Urology and Nephrology;2024-03-26

5. Antibiotic therapy impact on intravesical BCG therapy efficacy for high-risk localized bladder cancer treatment;Frontiers in Oncology;2024-03-08